The USFDA also completed a Pre-Approval Inspection (PAI) and cGMP audit, which concluded with zero Form 483 observations ...

Pharma player Granules India Limited on Friday said it has received an Establishment Inspection Report (EIR) from the US Food ...

FARMERS across the European Union are calling for an immediate rethink of the EU-Mercosur trade deal over fresh concerns with Brazilian production methods. It’s a deal that has created a great deal of ...

Granules India announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Unit V facility located at Jawaharlal Nehru Pharma ...

The outcome reflects the facility’s high standards in the production of active pharmaceutical ... a comprehensive pre-approval inspection (PAI) and cGMP audit, which concluded with zero Form 483 ...

In today’s data-driven landscape, sensitive information—like PII (Personally Identifiable Information), PHI (Protected Health Information), and PCI (Payment Card Information)—sprawls across enterprise ...

Hyderabad: Granules India Limited, a pharmaceutical manufacturing company, has announced that it has received an ...

and energy production facilities. Another area which has evolved since the last large-scale activity in the interior is the ...

Innovative approaches to waste reduction can involve material and time optimization, AI integration, workflow streamlining ...

The previously announced Glacier and Rio pads continue to perform above the Company’s type curve with cumulative production averaging 370 Mboe ... is primarily attributable to an increase in audit, ...

Second consecutive quarter of 20 ReWalk systemssoldRobust growth in U.S. ReWalk pipeline of approximately 70 qualified leads for potential claim ...